Last updated on October 2017

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices


Brief description of study

The purpose of this study is to gather data on patients diagnosed with and treated for classical Hodgkin Lymphoma (cHL). It aims to closely observe how treatment for cHL is rendered, as well as assess the outcome of those treatment options and their impact on quality of life. Additional analyses will also attempt to identify prognostic or predictive biomarkers

Clinical Study Identifier: NCT02856646

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Craig Rainbolt, Site 0001

Inventiv Clinical Health SHA LLC
Princeton, NJ United States
  Connect »